Neogenomics Inc (NEO) financials

Neogenomics Inc (NEO) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Neogenomics Inc reported revenue of $727M, up 10.1% year over year, net income of -$108M and free cash flow of -$22M.

Revenue (fiscal 2025)

$727M

Revenue growth (fiscal 2025)

10.1%

Net income (fiscal 2025)

-$108M

Free cash flow (fiscal 2025)

-$22M

Neogenomics Inc files with the U.S. Securities and Exchange Commission under CIK 0001077183, classified as Services-Testing Laboratories.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.